These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 34328248)

  • 1. Diet and exercise in NAFLD/NASH: Beyond the obvious.
    Semmler G; Datz C; Reiberger T; Trauner M
    Liver Int; 2021 Oct; 41(10):2249-2268. PubMed ID: 34328248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease.
    Semmler G; Datz C; Trauner M
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S244-S260. PubMed ID: 36517001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.
    Vancells Lujan P; Viñas Esmel E; Sacanella Meseguer E
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33923255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical nutrition therapy in non-alcoholic fatty liver disease--a review of literature.
    Rusu E; Enache G; Jinga M; Dragut R; Nan R; Popescu H; Parpala C; Homentcovschi C; Nitescu M; Stoian M; Costache A; Posea M; Rusu F; Jinga V; Mischianu D; Radulian G
    J Med Life; 2015; 8(3):258-62. PubMed ID: 26351523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial.
    Liu WY; Lu DJ; Du XM; Sun JQ; Ge J; Wang RW; Wang R; Zou J; Xu C; Ren J; Wen XF; Liu Y; Cheng SM; Tan X; Pekkala S; Munukka E; Wiklund P; Chen YQ; Gu Q; Xia ZC; Liu JJ; Liu WB; Chen XB; Zhang YM; Li R; Borra RJ; Yao JX; Chen PJ; Cheng S
    BMC Public Health; 2014 Jan; 14():48. PubMed ID: 24438438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Roeb E; Geier A
    Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
    Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
    JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches.
    Armandi A; Schattenberg JM
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34201382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Katsagoni CN; Papachristou E; Sidossis A; Sidossis L
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32961669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.
    Kwak MS; Kim D
    Korean J Intern Med; 2018 Jan; 33(1):64-74. PubMed ID: 29202557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review.
    Alalwani J; Eljazzar S; Basil M; Tayyem R
    Clin Obes; 2022 Aug; 12(4):e12525. PubMed ID: 35412016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of NAFLD with diet, physical activity and exercise.
    Romero-Gómez M; Zelber-Sagi S; Trenell M
    J Hepatol; 2017 Oct; 67(4):829-846. PubMed ID: 28545937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
    Kim SK; Kim KI; Kim SR
    Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review.
    Parry SA; Hodson L
    Adv Ther; 2020 Apr; 37(4):1381-1406. PubMed ID: 32146704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
    Alwahsh SM; Gebhardt R
    Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Africa JA; Newton KP; Schwimmer JB
    Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Lifestyle Interventions in NAFLD.
    Houghton D; Stewart CJ; Day CP; Trenell M
    Int J Mol Sci; 2016 Mar; 17(4):447. PubMed ID: 27023533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of diet and lifestyle changes in nonalcoholic fatty liver disease.
    Nseir W; Hellou E; Assy N
    World J Gastroenterol; 2014 Jul; 20(28):9338-44. PubMed ID: 25071328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.